Tue, 8 December 2020
In this episode, Hall welcomes Bernard Vogel, Co-founder and Managing Partner at Endeavour Vision.
Endeavour Vision is a leading private equity firm exclusively investing in medical technology. This singular focus requires deep sector knowledge and experience, so their team is made up of industry veterans and investment professionals who are experts in the medtech sector. Their specialties include accelerating company growth and product launches with a proven track record of successful exits.
They invest in growth-stage companies with world-class technology and products. These innovations address an unmet clinical need and hold the potential to significantly improve and extend the lives of patients around the world.
Bernard leads the operational, financial, investor relations, HR, and legal aspects of the firm, and is a board member of several investments, including IntelyCare – a staffing platform for medical personnel. Prior to launching Endeavour in 2000, Bernard worked with McKinsey & Co.
Bernard holds an MBA with distinction from INSEAD in Fontainebleau (France), and an MEng in Mechanical and Industrial Engineering from the Swiss Federal Institute of Technology, Zurich, Switzerland.
Bernard tells Hall what excites him right now, and he advises both entrepreneurs and investors in the space. He discusses the impact COVID-19 has had on the sector and mentions two startups that fit Endeavour Vision’s investment thesis.
You can visit Endeavour Vision at www.endeavourvision.com.
Direct download: Bernard_Vogel_of_Endeavour_Vision.mp3
Category: -- posted at: 12:30pm CST
Tue, 8 December 2020
Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.
In startup fundraising, there’s money and then there’s smart money.
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Feedback please contact firstname.lastname@example.org